Literature DB >> 21985025

Oral isotretinoin and pregnancy prevention programmes.

D Thiboutot, H Gollnick, V Bettoli, B Dréno, S Kang, J J Leyden, A Shalita, V Torres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21985025     DOI： 10.1111/j.1365-2133.2011.10686.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.

Authors:  James J Leyden; James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

2.  A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.

Authors:  James Q Del Rosso; Sandra Marchese Johnson; Todd Schlesinger; Lawrence Green; Nestor Sanchez; Edward Lain; Zoe Draelos; Jean-Philippe York; Rajeev Chavda
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

3.  [Isotretinoin. How should it be used?].

Authors:  A Thielitz; H Gollnick
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

4.  Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016.

Authors:  Anneli Uusküla; Heti Pisarev; Katrin Kurvits; Ott Laius; Made Laanpere; Maia Uusküla
Journal:  Drugs Real World Outcomes       Date:  2018-06

5.  Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience.

Authors:  Vincenzo Bettoli; Aurora Guerra-Tapia; Maria Isabel Herane; Jaime Piquero-Martín
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.